Macquarie Group’s Adamas Pharmaceuticals ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,799,420
Closed -$5.2M 2424
2020
Q1
$5.2M Sell
1,799,420
-367,996
-17% -$1.65M 0.01% 706
2019
Q4
$8.21M Sell
2,167,416
-93,262
-4% -$446K 0.01% 685
2019
Q3
$11.6M Sell
2,260,678
-151,480
-6% -$935K 0.02% 575
2019
Q2
$15M Sell
2,412,158
-209,542
-8% -$1.21M 0.03% 527
2019
Q1
$18.6M Sell
2,621,700
-86,517
-3% -$778K 0.03% 478
2018
Q4
$23.1M Buy
2,708,217
+923,099
+52% +$12M 0.04% 392
2018
Q3
$35.7M Buy
1,785,118
+474,808
+36% +$11.1M 0.06% 345
2018
Q2
$33.8M Buy
1,310,310
+145,412
+12% +$4.03M 0.06% 356
2018
Q1
$27.8M Buy
1,164,898
+273,936
+31% +$8.64M 0.05% 387
2017
Q4
$30.2M Buy
890,962
+139,934
+19% +$3.91M 0.05% 370
2017
Q3
$15.9M Buy
+751,028
New +$13.8M 0.03% 502

Other funds holding ADMS